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Abstract: Theodore Boveri, eminent German pathologist, observed aneuploidy in cancer cells more than a century ago 
and suggested that cancer cells derived from a single progenitor cell that acquires the potential for uncontrolled continu-
ous proliferation. Currently, it is well known that aneuploidy is observed in virtually all cancers. Gain and loss of chromo-
somal material in neoplastic cells is considered to be a process of diversification that leads to survival of the fittest clones. 
According to Darwin’s theory of evolution, the environment determines the grounds upon which selection takes place and 
the genetic characteristics necessary for better adaptation. This concept can be applied to the carcinogenesis process, con-
necting the ability of cancer cells to adapt to different environments and to resist chemotherapy, genomic instability being 
the driving force of tumor development and progression. What causes this genome instability? Mutations have been rec-
ognized for a long time as the major source of genome instability in cancer cells. Nevertheless, an alternative hypothesis 
suggests that aneuploidy is a primary cause of genome instability rather than solely a simple consequence of the malignant 
transformation process. Whether genome instability results from mutations or from aneuploidy is not a matter of discus-
sion in this review. It is most likely both phenomena are intimately related; however, we will focus on the mechanisms in-
volved in aneuploidy formation and more specifically on the epigenetic origin of aneuploid cells. Epigenetic inheritance is 
defined as cellular information—other than the DNA sequence itself—that is heritable during cell division. DNA methyla-
tion and histone modifications comprise two of the main epigenetic modifications that are important for many physiologi-
cal and pathological conditions, including cancer. Aberrant DNA methylation is the most common molecular cancer-cell 
lesion, even more frequent than gene mutations; tumor suppressor gene silencing by CpG island promoter hypermethyla-
tion is perhaps the most frequent epigenetic modification in cancer cells. Epigenetic characteristics of cells may be modi-
fied by several factors including environmental exposure, certain nutrient deficiencies, radiation, etc. Some of these altera-
tions have been correlated with the formation of aneuploid cells in vivo. A growing body of evidence suggests that ane-
uploidy is produced and caused by chromosomal instability. We propose and support in this manuscript that not only ge-
netics but also epigenetics, contribute in a major fashion to aneuploid cell formation. 
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INTRODUCTION 
  Chromosome number is transmitted with a high rate of 
fidelity to daughter cells in each cell division. Deviation 
from normal chromosome number leading to an unbalanced 
chromosome complement or to any chromosome number 
that is not an exact multiple of the haploid number is referred 
to as aneuploidy. In humans, aneuploidy has different clini-
cal consequences depending on the cell type affected. If 
germinal cells are affected, aneuploidy is responsible for 
nearly 20% of spontaneous abortions, most frequently within 
the first semester, affecting mainly women aged >35 years. 
Nonetheless, aneuploidy affecting certain combinations of 
sex chromosomes and small chromosomes such as 13, 18, 
and 21 may be present in products that survive to gestation, 
although with birth defects, abnormal development, infertil-
ity, mental retardation, and early death in some cases. If ane-
uploidy occurs in somatic cells, it could result in apoptosis or  
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chromosomal instability, the latter strongly associated with 
generation, aggressiveness, and resistance of cancer cells [1]. 
  The causes of aneuploidy and chromosomal instability 
remain largely unknown. Many experiments support the hy-
pothesis of a genetic cause of aneuploidy and chromosomal 
instability; notwithstanding this, it is important to point out 
that the human genome is contained in chromosomes, whose 
structure is more than a simple array of genes, and one that 
determines chromosomal behavior during mitosis and meio-
sis, distribution of genes to daughter cells a direct conse-
quence of this behavior. In fact, the human genome contains 
a large proportion of DNA that forms highly repeated short 
DNA sequences incapable of coding for proteins; this may 
play a role in the stabilization and normal functioning of 
chromosomes that can be implicated in the normal segrega-
tion process and in prevention of genomic instability.  
  It is now accepted that gene expression and chromosome 
biology are largely affected by epigenetic marks within 
chromosomes. These marks occur in the chromatin of eu-
karyotic genomes, are present in both DNA and the associ-
ated histones, and are stable throughout rounds of cell divi- 
 44    Current Genomics, 2008, Vol. 9, No. 1  Herrera et al. 
sion but do not involve changes in the organism’s underlying 
DNA sequence. Epigenetic changes play a role in the cellular 
differentiation process, allowing cells to maintain differential 
gene expression stably despite containing the same genomic 
material. Epigenetic information is also essential for the 
formation of heterochromatin, which is highly compacted, 
not so accessible to transcription and recombination machin-
ery as are other chromosome regions, and forms structured 
nucleosome arrays. These characteristics of heterochromatin 
depend on epigenetic marks that include post-translational 
modifications of histones and DNA methylation. Although 
for some time the repetitive DNA contained in heterochro-
matin was considered as “junk”, recent evidence indicates 
that heterochromatin can also play important roles during 
chromosome segregation. Therefore, epigenetics is not only 
important for genome expression, but also for its correct seg-
regation during mitosis and meiosis. 
  Here, we review the role of DNA methylation in chromo-
some stability and the impact of modifications on this epige-
netic mark in correct chromosome segregation, with special 
emphasis on cancer cells. This is not only because the major-
ity of experiments have been carried out either in tumor cells 
or in cancer cell lines, but also due to the importance of ane-
uploidy and epigenetics in carcinogenesis. Currently, it is 
well known that aneuploidy is observed in virtually all can-
cers. Gain and loss of chromosomal material in neoplastic 
cells is considered a process of diversification that leads to 
survival of the fittest clones. Cancer, on the other hand, in-
volves both global and gene-specific hypomethylation and 
hypermethylation, as well as widespread chromatin modifi-
cations [2]. 
THE CLASSIC CONCEPT OF THE ORIGIN OF 
ANEUPLOIDY 
  Induction of aneuploidy has been associated with defects 
in chromosome segregation resulting from mitotic spindle 
alterations, centrosome amplifications, cell-cycle checkpoint 
defects, non-separation of chromatids, and telomere stability, 
among others. The classical point of view is that these altera-
tions are induced mainly by mutations in some genes that 
control chromosome segregation. More than 100 genes are 
expected to cause chromosomal instability when mutated in 
eukaryotic cells, including genes involved in telomere me-
tabolism, chromatid cohesion, spindle assembly and dynam-
ics, cell-cycle regulation, DNA repair, and checkpoint con-
trols [3]. However, some important genes are not mutated in 
aneuploid cells, but are expressed aberrantly [4]. 
  Centrosome proteins such as Aurora kinases may con-
tribute to aneuploidy and usually are overexpressed in cancer 
cell lines. Aurora A overexpression is associated with cen-
trosome amplification and generation of polyploid cells con-
taining multiple centrosomes. Aurora A overexpression also 
overrides the spindle assembly checkpoint, resulting in ar-
rested mitosis with incomplete cytokinesis and leading to 
taxol resistance-associated multinucleation [5].  
  Studies with pre-invasive lesions found a high frequency 
of centrosome defects in addition to spindle abnormalities, 
correlated with a high rate of progression to cancer [6]. In 
the same way, low prevalence of centrosome defects was 
associated with low-grade lesions. Also, centrosome amplifi-
cations have been detected in in situ-stage breast carcinoma 
cells, indicating that these may develop early in the neoplas-
tic process [6]. Centrosome amplification can be associated 
with diverse genes. For instance, centrosome duplication is 
controlled by Cdk2/cyclin E complex, which is inhibited by 
p21. Thus, overexpression of cyclin E or p21 inhibition re-
sults in centrosome amplification; moreover, dysfunction of 
p53, a positive p21 regulator, has the same outcome [7]. Plk1 
is necessary for centrosome maturation, is overexpressed in 
many tumors, and correlates with poor prognosis [8]. 
  Failure in the DNA damage response and double-strand 
break repair can lead to genetic alteration or chromosomal 
instability. Similarly, defects in cellular response to double-
strand breakage result in genetic mutations, gene amplifica-
tion, and chromosomal aberrations, and are associated with 
cancer [9]. For example, ATR activation culminates in cell-
cycle arrest, apoptosis, and in DNA repair alteration. ATR 
has been shown to be a critical factor in the maintenance of 
chromosomal integrity, and its inhibition leads to chromo-
somal instability and overexpression of fragile sites. ATM 
and ATR function as key molecules in the DNA damage 
response, with a strong influence on the control of cell-cycle 
checkpoints, DNA repair, telomere maintenance, and apop-
tosis [10]. Many other specific DNA damage response genes 
and hereditary mutations in genes such as histone H2AX 
[11], mre11A, CHEK1, BRCA1, and -2 have been associated 
with chromosomal instability, and have been shown to cause 
tumor predisposition  by initiating chromosomal instability 
[12-13]. 
  Some experiments suggest that short telomeres could 
possess a key role in chromosomal instability, as observed in 
telomerase-negative immortalized cells, which tend to de-
velop a tetraploid cell population [14]. Polyploidization is an 
event occurring concurrently with gradual loss of individual 
chromosome copies. Some preneoplastic lesions, such as 
Barrett’s esophagus [15] and ulcerative colitis [16], have a 
high frequency of tetraploid cells. In fact, it has been sug-
gested that some aneuploid cancer cells develop through a 
tetraploid intermediate [17]. 
  The function of the spindle checkpoint is to ensure that 
all chromosomes are correctly aligned in metaphase cells and 
properly attached to the mitotic spindle before chromosome 
separation can proceed. Chromosomally instable cancer cells 
in tissue culture do not arrest in metaphase when incubated 
with microtubule-disrupting agents, most likely due to an 
abnormal mitotic checkpoint. Spindle checkpoint defects 
also have been demonstrated in head and neck cancer cell 
lines [18]. Spindle checkpoint gene mutations were initially 
reported in colon and pancreatic cancer, as well as in a single 
breast cancer cell line [19]. However, further analyses re-
vealed that mutations in these genes are rather uncommon; 
therefore, chromosomal instability in tumors is due to other 
factors. Subsequent investigations have demonstrated aber-
rant expression of spindle checkpoint genes (over- and sub-
expression) rather than chromosomal instability-related mu-
tations [4, 20-22]. Mutations and control of chromosome 
segregation genes such as hZW10, -ILCH, and hROD have 
also been identified as playing a role in the stabilization of 
this structure, and their dysfunction might contribute to the 
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DNA METHYLATION AND INDUCTION OF CHRO-
MOSOMAL INSTABILITY 
  Although there are several important elements involved 
in the generation and maintenance of epigenetic marks, we 
will focus on DNA methylation and its contribution to chro-
mosome stability. Excellent reviews on the elements that 
make up the DNA methylation machinery have been pub-
lished recently. Nevertheless, we consider it important to 
describe briefly some of the most relevant characteristics of 
this process. 
  DNA methylation is the covalent attachment of a methyl 
group from S-adenosyl-methionine (SAM) to carbon 5 of the 
cytosine ring [23]. It is one of the best studied factors in-
volved in cellular epigenetics and is considered an important 
gear in the chromatin compactation and maintenance proc-
ess. In constitutive heterochromatin, DNA methylation is 
directed by post-translational modifications of histones and 
completed by proteins, such as methyl-binding proteins, 
which are characterized by a chromodomain that binds spe-
cifically to methylated DNA and recruits enzymatic com-
plexes, e.g., histone deacetylases. This model has been ex-
tensively reviewed elsewhere [24] and is currently used to 
explain the perpetuation of epigenetic modifications that 
derive in constitutive heterochromatin region formation. In 
facultative heterochromatin and in maintenance methylation, 
the epigenetic signal lies in the parental strand and corre-
sponds to a methylated cytosine [25]. 
  The enzymes directly involved in DNA methylation are 
known as DNA-methyltransferases, or Dnmts. Mammals in 
general express three families of Dnmts: Dnmt1; -2, and -3 
[26-27]. All mammalian Dnmts known to date possess a 
common catalytic domain that is characterized by 10 con-
served amino acid motifs implicated in the catalytic function. 
Dnmt1 and -3 enzymes contain a large N-terminal regulatory 
domain responsible for the differential function between 
them.  
  Dnmt1 is highly expressed in somatic differentiated cells 
and is responsible for generation of methylation patterns in 
many daughter cells after differentiation. In other words, this 
enzyme is responsible for DNA methylation perpetuation in 
promoter regions of tissue-specific genes, juxtacentromeric 
satellites, and imprinting control regions, although its work 
in maintenance methylation may be complemented by the 
remaining Dnmts [28]. This enzyme recognizes an asymmet-
ric specific methylated sequence for transferring the methyl 
group to the newly incorporated cytosine. Hemimethylation 
is an essential process to maintain DNA methylation patterns 
during cell proliferation, because any mistake—including 
alterations in methylation machinery and/or methyl group 
bioavailability—could generate important scarring in the 
epigenome. It has been shown, with the use of demethylating 
de novo agents, that hypomethylating stress may induce 
changes in the methylation pattern that can be conserved 
even in absence of the substance.  
  Dnmt3a, -b, and -L generate methylation, establish the 
methylation pattern, and are highly expressed in embryonic 
stage [29]. DNA methylation is conserved throughout a long 
time period and many cell cycles [30]. An important compo-
nent of this cascade of events comprises proteins with a 
chromodomain, called Methyl-CpG-binding proteins, which 
interact with either histone deacetylases or histone methyl-
transferases and other enzymatic complexes to create a com-
pacted chromatin [31]. 
  It is important to emphasize genome structures in somatic 
cells that are normally DNA methylated. Some of these 
structures are involved in the process of chromosome segre-
gation and genome stabilization. In our laboratory, we have 
found that this pattern of methylation, which involves impor-
tant chromosomal structures, changes with response to 
chemical compounds (Fig. 1), with important consequences 










Fig. (1). Chromosome methylation patterns of human lymphocytes treated with ethionine or colchicine. Methylation patterns were revealed 
using a FITC-5methyl-cytosine antibody. A) Normal pattern; B) cells treated with colchicine; C) cells treated with ethionine. Methylation 
(arrows) is localized in pericentromeric and in some subtelomeric areas in control cultures, while the methylation pattern is localized along 
the chromosomes in colchicine-treated cells, or in subtelomeric areas in ethionine-treated cells. 46    Current Genomics, 2008, Vol. 9, No. 1  Herrera et al. 
DNA Methylation and Chromosome Instability 
  Cells with reduced DNA methylation levels appear to be 
more susceptible to undergoing chromosomal loss, gain, or 
rearrangement, probably because hypomethylation reduces 
chromosomal stability [32]. Experiments performed with 
embryonic stem cells show that cells suffered global DNA 
hypomethylation after Dnmt3b inactivation, generating 
chromosomal instability characterized by aneuploidy, poly-
ploidy, and some forms of chromosomal aberrations such as 
chromosomal breaks and fusions. DNA hypomethylation 
was also associated with premature senescence or spontane-
ous immortalization [33].  
  Global hypomethylation in male germ cells may also 
result in meiotic abnormalities [34-35]. DNA demethylating 
drugs such as 5-azacytidine, a cytidine analogue [36], and its 
derived 5-aza-2' deoxycytidine, induce progressive increase 
in micronuclei formation. These demethylating substances 
lead to chromosomal aberrations such as deletions, chromo-
some breaks, isochromosome formation, and translocations 
[37]. In some cases, these substances induce undercondensa-
tion and somatic pairing among the constitutive heterocro-
matin of chromosomes 1, 9, and 16, 90% of these involving 
pericentromeric regions [38], figures denominated multi-
branched chromosomes, and delay in the centromere separa-
tion sequence [39], generating preferential exclusion of 
chromosomes 1, 9, and 16 in micronuclei [40-41], as well as 
uncoiling and recombination in classical satellite-containing 
constitutive heterochromatin, but not in alpha satellite [42].  
  5-azacytidine, ethionine, and 9-b-D-arabinofuranosyl-
adenine-induced hypomethylation increases sister chromatid 
exchange (SCE) formation in mammalian cells [43]. SCEs 
occur only after a second cell cycle following the demethy-
lating pulse, indicating that the key event comprises demeth-
ylation of the old parental DNA strand. SCE persisting for 
many cell cycles after removal of the demethylating pulse 
may be due to methylation maintenance mechanisms [44].  
  At our laboratory, we have found that in cells exposed to 
aneugenic compounds, the chromosomal pattern of methyla-
tion changes, with an important reduction of the pericentro-
meric normal methylation that has been correlated with ane-
uploid cell formation. Changes in the methylation pattern of 
chromosomes has been previously described in Epstein-Barr-
virus-transformed monocytes [45] and in sodium arsenite-
treated immortalized cells [46]; nonetheless, its relationship 
with aneuploidy has not been evaluated.  
DNA Methylation in Sub-Telomeric and Telomeric Re-
gions 
  Telomeres are nucleoproteic structures at the end of chro- 
mosomes that consist of tandem repeats of the TTAGGG 
sequence, which is bound by associated proteins [47]. Te-
lomere length is regulated by telomerase, a reverse tran-
scriptase, by alternative telomere lengthening and by histone 
modifications and sub-telomeric methylation [48]. Telomere 
function is also controlled by proteins such as TRF1, -2, 
POT1, TIN2, and Rap1, a mammalian telomeric core com-
plex that forms and protects the telomere [49]. Mammalian 
telomeres contain histone modifications such as the H3K9 
di- and trimethylation produced by histone-methyltransferases 
Suv39h1 and -2 [50], trimethylation of H4K20 by Suv420h1 
and -2, and the retinoblastoma family of proteins, as well as 
the binding of CBX1, -3, and -5 [51].  
  Sub-telomeric regions are rich in repetitive DNA, have a 
high density of CpG sequences, and are methylated in human 
somatic cells [52] observed by cytogenetic methods [53]. 
The short arms of acrocentric chromosomes 13, 14, 15, 21, 
and 22 correspond to high concentrations of methylated 
CCGG repeats at the end of the chromosomes [54]. When 
epigenetic changes are lost, telomere elongation takes place, 
suggesting that a compacted chromatin state is fundamental 
for controlling telomere length. Lack of Dnmts also in-
creases telomeric recombination, indicating that DNA meth-
ylation protects the genome from illegitimate recombination 
between repetitive sequences of telomeres. Loss of methyl 
groups in telomeres by knock-out of the Dnmt3b has been 
correlated with the presence of SCE in stem cells [48].  
  Recent reviews analyze the mechanisms implicated in 
telomere dysfunction-associated chromosome instability 
formation [49] and the importance of this phenomenon in the 
stability of the genome; nonetheless, the significance of 
methylation patterns in sub-telomeric regions in chromoso-
mal instability induction has not been studied yet in depth. 
Nevertheless, in experiments with ICF cell lines the model of 
functional depletion of one of the de novo enzymes, 
Dnmt3b, demonstrate telomeric associations and clonal te-
lomeric rearrangements between chromosomes and anaphase 
bridges. These are increased by the presence of short dys-
functional telomeres among various chromosomes [55], sug-
gesting that sub-telomeric methylation may be mediated by 
Dnmt3b.  
  Sodium arsenite, a substance associated with DNA de-
methylation, generates nucleoplasmic bridges and Break-
age/Fusion/Bridge (B/F/B) cycles, as well as telomeric asso-
ciations and dicentric chromosomes, conferring a selective 
advantage on proliferation associated with an aneuploid state 
[46].  
  The DNA methylation inhibitor 5-azacytidine has also 
been able to induce telomeric fusions. Cancer cells com-
monly possess telomere instability [49, 55-56], and tumor 
cell lines have lost telomeres at a high rate (10
–6 events per 
cell per generation). In tumor cell lines, telomere loss often 
results in sister chromatid fusion followed by B/F/B cycles 
[57] lasting for many generations. This inability to terminate 
B/F/B cycles is likely to contribute to the chromosome insta-
bility resulting from telomere loss in human tumor cells. 
Also, telomere function loss and cell-cycle control disruption 
are capable of triggering extensive chromosomal instability 
in colon cancer cells [58]. However, loss of sub-telomeric 
methylation in cancer and its role in the perpetuation of 
chromosomal instability in cancer cells has not been studied 
to date. 
DNA Methylation at Pericentromeric Regions 
  Pericentromeric regions, the areas surrounding the cen-
tromere, are characterized by highly repetitive DNA seg-
ments termed classical satellites 2 and 3, which are mainly 
non-transcribed and highly methylated. These regions con-
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matin and are located at metacentric and sub-metacentric 
chromosomes 1, 9, and 16, and in the short arms of some 
acrocentric chromosomes such as 13, 14, 15, 21, and 22. 
Based on ICF syndrome findings, Ehrlich found a relation-
ship between satellite 2 hypomethylation and induction of 
centromeric decondensation [59]. Pericentromeric region 
hypomethylation is associated with the induction of a sig-
nificant reorganization of constitutive pericentromeric het-
erochromatin [60] and can be clearly observed in cells from 
patients with ICF syndrome [61].  
  Somatic cells from patients with ICF exhibit hypomethy-
lated pericentromeric regions associated with chromosomal 
rearrangements, centromere under-condensation, and the 
formation of micronuclei preferentially containing chromo-
somes 1, 9, and 16 [32]. Defects in pericentromeric epige-
netic heterochromatin modifications initiate a dynamic HP1-
dependent response that rescues pericentromeric hetero-
chromatin function and is essential for viable progression 
through mitosis [62].  
  Efficient DNA methylation of pericentromeric sequences 
requires previous trimethylation H3K9 (histone 3 lysine 9) 
by Suv39h histone methyltransferases [63]. Experimentally 
induced Suv39h1 overexpression increases trimethylation at 
H3K9, and is associated with defects in mitotic progression 
and chromosome segregation [64]. However, mice lacking 
Suv39h do not exhibit trimethylation at H3K9 within 
pericentromeric heterochromatin, but rather present in-
creased genomic instability and cancer predisposition [65]. 
Pericentromeric regions have also been found hypomethy-
lated in some cancers, including hepatocarcinoma, breast, 
urothelial, and ovarian cancer, and this condition was associ-
ated with poor prognosis [66-67].  
Chromosome Instability and Aneuploidy Induced by 
Factors Modifying Epigenetic Marks 
  One characteristic of epigenetic marks is that they can be 
modified by genetic and environmental factors, which also 
induce chromosome instability and aneuploidy. For instance, 
the ICF syndrome (Immunodeficiency, Centromeric instabil-
ity, Facial abnormalities), is a rare genetic disease in which 
some mutations in the Dnmt3b gene have been detected. 
These mutations not only affect the activity of the enzyme, 
but also reduce affinity by Dnmt3L [68]. Cells from patients 
with ICF syndrome present repetitive Alu sequence demeth-
ylation [69], satellites 2 and 3 preferentially at pericentro-
meric regions [70], and hypomethylation of the CpG island 
of genes located at the inactive X chromosome and of non-
satellite DNA repeats D4z4 and NBL2 [71]. These cells also 
present multiple chromosomal aberrations such as isochro-
mosomes, multibranched chromosomes, and breaks. In addi-
tion to the high frequency of chromosomal instability ob-
served in patients with ICF, they do not develop cancer at a 
higher frequency than the general population, most likely 
due to their short life span (survival to 10 years of age) [61].  
  Chemical substances such as cadmium, nickel, and so-
dium arsenite have been categorized as human carcinogens 
[72], affecting epigenetic marks by different mechanisms. 
Cadmium chloride induces aneuploidy in MRC-5 human 
cells [73-74], as well as in other animal models [75-76]. 
Cadmium inhibits both mammalian and bacterial Dnmt in 
vitro and ex vivo [77-78] in a non-competitive manner, indi-
cating an interaction with the DNA binding domain, proba-
bly at the cysteine residue in the active center of Dnmts [79]. 
This induces DNA hypomethylation early in the cell cycle. 
Prolonged exposure to cadmium induces signs of cell trans-
formation such as altered cell morphology, increased inva-
siveness, and increased growth rate accompanied by DNA 
hypermethylation and enhanced Dnmt activity [78]. 
  Exposure to inorganic arsenic, which interferes with 
normal methyl- group metabolism, represses expression of 
DNA methyltransferase genes Dnmt1 and -3a [80]. Sodium 
arsenite generates hypomethylation and changes in chromo-
some methylation patterns after acute exposure [46] that are 
maintained throughout several cell cycles without the sub-
stance. Also, arsenic-induced results in c-myc overexpres-
sion in TRL 1215 cells is probably associated with many 
other changes, such as hypomethylation, which is strongly 
correlated with malignant capacity [81]. Studies in exposed 
humans found significant DNA hypermethylation of p53 and 
-16 promoter regions in arsenic-exposed persons [82]. 
  Nickel compounds are potent human and rodent carcino-
gens [83] and produce chromosome instability and ane-
uploidy in mammalian cells [84]. The carcinogenic potential 
of nickel compounds is thought to involve oxidative stress, 
genomic DNA damage, and epigenetic effects, including 
gene silencing. Nickel is a DNA methyltransferase activity 
inhibitor  in vitro and in vivo and induces an initial DNA 
methylation decrease but with a rebound elevation of total 
DNA methylation [85]. Water-insoluble nickel compounds 
induce gene silencing by DNA methylation as a result of de 
novo methylation, being one of the first models of possible 
epigenetic carcinogenesis [86]. Short-term exposure of cells 
to crystalline nickel particles (1–3 days) silences, epigeneti-
cally, target genes placed near heterochromatin. A similar 
effect was found in yeast cells, in which nickel was able to 
silence the URA-3 gene while it is placed near a telomere 
silencing element [87-88]. Recently, it was discovered that 
this change was associated with a decrease in histone H3 and 
-4 acetylation, as well as an increase in histone H3K9 di-
methylation, and that nickel decreased histone demethylase 
activity [89].  
  Folates are important methyl-group donors for DNA 
methylation. Nearly two decades ago, it was observed that 
cells from patients with folate and B12 vitamin deficiencies 
have chromosomal abnormalities that persisted up to 12 
months after hematological remission [90]. A study with 
postmenopausal women in whom moderate folate depletion 
was induced with a folate-deficient diet demonstrated in-
creased chromosome missegregation frequency in their pe-
ripheral blood lymphocytes associated with a decrease on 
DNA methylation [91]. Similarly, a 3-month 700-g folate 
and 7-g vitamin B12 supplementation was associated with a 
lower frequency of micronuclei in young persons [92]. Re-
cently, it has been suggested that folic acid deficiency may 
increase not only micronuclei, but also the frequency of nu-
clear budding and nucleoplasmic bridges, suggesting that 
folate depletion plays a role in B/F/B cycle initiation [93]. 
Indeed, some authors have pointed out that folate depletion 
may be a factor associated with chromosomal instability in-
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BRCA1 or -2 [94]. Nevertheless, other group, working with 
human erythrocytes, reported that folate supplementation did 
not reduce chromosome missegregation frequency [95].  
CONCLUSIONS 
  The molecular basis of heritable epigenetics and its ef-
fects on gene expression have been studied in a variety of 
organisms and associated with several human diseases. Al-
though it is known that epigenetic marks influence chromatin 
structure, the potential role of epigenetics in the control of 
chromosome stability and segregation is still poorly under-
stood. DNA methylation, one of the most important epige-
netic marks, influences chromatin dynamics in chromosome 
areas that are essential for chromosome stability and segre-
gation, such as sub-telomeric and pericentromeric regions, 
either directly or indirectly through its influence on histone 
acetylation and histone methylation. The mammalian pattern 
of DNA methylation acquired during embryogenesis is 
maintained stably but is potentially affected by the environ-
ment; these changes can affect chromosome behavior result-
ing in alterations in chromosome segregation. The evidence 
presented strongly suggest an important role of epigenetic 
marks in the control of chromosome segregation and integ-
rity. Also, considering the importance of aneuploidy in the 
generation of human pathologies it is important to perform 
additional investigative efforts to obtain better understanding 
of the genetic and epigenetic mechanisms that control chro-
mosome integrity and segregation.  
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